Avant Diagnostics Inc Stock
Equities
US05350M1062
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2021 | Avant Diagnostics : AvidXchange Shares Fall in Trading Debut | MT |
2021 | Avant Diagnostics : AvidXchange Prices IPO at $25 Per Share | MT |
Managers | Title | Age | Since |
---|---|---|---|
Michael Ruxin
CEO | Chief Executive Officer | 78 | 17-11-30 |
Thomas Chilcott
DFI | Director of Finance/CFO | 56 | 20-09-23 |
Glenn D. Hoke
CTO | Chief Tech/Sci/R&D Officer | - | 16-05-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeffrey Busch
CHM | Chairman | 66 | 18-05-24 |
Michael Ruxin
CEO | Chief Executive Officer | 78 | 17-11-30 |
Director/Board Member | 43 | - |
1st Jan change | Capi. | |
---|---|---|
-18.16% | 11.13B | |
+58.43% | 3.6B | |
-31.31% | 2.26B | |
-14.31% | 2.16B | |
-26.61% | 1.54B | |
+34.35% | 1.17B | |
-3.28% | 744M | |
-22.75% | 482M | |
-40.20% | 432M |
- Stock Market
- Equities
- Stock